Mirum Pharmaceuticals Accounts Payable

Mirum Pharmaceuticals (MIRM) currently reports a accounts payable of $23M as of June 2026. That compares with $18M in the prior-year period — up 32.7% year over year. Use the charts on this page to explore Mirum Pharmaceuticals's accounts payable history and peer comparisons.

Mirum Pharmaceuticals's accounts payable increased from $18M to $23M — a 32.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mirum Pharmaceuticals reported $23M in accounts payable as of June 2026. That compares with $18M in the prior-year period — up 32.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mirum Pharmaceuticals, and consider following MIRM for alerts when major investors trade the stock.

Mirum Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MIRM with unrelated industries.